Refractory cardiogenic shock in an infant with congenital hypothyroidism

Syed Ahmed Zaki1, Amit Dolas

  • 1Department of Pediatrics, Lokmanya Tilak Municipal Medical College and General Hospital, Sion, Mumbai-400 022, India.

Insights

Congenital hypothyroidism can cause severe heart problems, including refractory cardiogenic shock, in infants. Prompt treatment with levothyroxine therapy successfully restored cardiac function and hemodynamic stability in a rare case.

Area of Science:

  • Pediatric Cardiology
  • Endocrinology
  • Neonatal Health

Background:

  • Thyroid dysfunction significantly impacts cardiovascular function, potentially causing heart failure and arrhythmias.
  • Congenital hypothyroidism, a rare condition, can manifest with severe cardiac complications.
  • Refractory cardiogenic shock and hypotension are uncommon but critical presentations in infants with congenital hypothyroidism.

Observation:

  • A 5-month-old female infant presented with congenital hypothyroidism.
  • The infant exhibited refractory cardiogenic shock and hypotension.
  • This presentation is considered rare in the context of congenital hypothyroidism.

Findings:

  • Cardiac function was significantly impaired in the infant.
  • Hemodynamic instability was a critical concern.
  • Levothyroxine therapy was initiated to address the hypothyroidism.

Implications:

  • Early diagnosis and treatment of congenital hypothyroidism are crucial for preventing severe cardiac sequelae.
  • Levothyroxine therapy can effectively reverse cardiac dysfunction and improve hemodynamic stability in affected infants.
  • This case highlights the importance of considering cardiac complications in neonatal hypothyroidism and the efficacy of timely intervention.

Related Concept Videos

Hypothyroidism II: Pathophysiology01:23

Hypothyroidism II: Pathophysiology

Hypothyroidism is a disorder characterized by insufficient production of thyroid hormones, which regulate metabolism, energy balance, and multiple organ systems.TypesHypothyroidism is classified based on the level of dysfunction. Primary hypothyroidism results from intrinsic thyroid gland dysfunction, causing reduced hormone production despite normal or increased stimulation. Secondary hypothyroidism arises from inadequate thyroid-stimulating hormone (TSH) secretion by the pituitary. Tertiary...
Cardiopulmonary Resuscitation IV: Pharmacological Management01:25

Cardiopulmonary Resuscitation IV: Pharmacological Management

Pharmacologic intervention is crucial in treating cardiac arrest patients during ACLS or Advanced Cardiovascular Life Support. The ACLS algorithms guide the administration of specific drugs based on the patient's cardiac arrest rhythm, which includes pulseless ventricular tachycardia (VT), ventricular fibrillation (VF), asystole, and pulseless electrical activity (PEA).EpinephrineIndication: Epinephrine is the first-line drug for all cardiac arrest rhythms.Mechanism of Action: Epinephrine...
Cardiomyopathy IV: Restrictive Cardiomyopathy01:29

Cardiomyopathy IV: Restrictive Cardiomyopathy

Restrictive cardiomyopathy (RCM) is a rare heart muscle disease characterized by impaired ventricular filling due to stiffened ventricular walls, leading to significant diastolic dysfunction.EtiologyRestrictive cardiomyopathy can arise from both inherited and acquired diseases, many of which are systemic. It is categorized into four main types: infiltrative, storage, non-infiltrative, and endomyocardial diseases.Infiltrative diseases, such as amyloidosis, lead to RCM by depositing amyloid...
Hyperthyroidism II: Pathophysiology01:27

Hyperthyroidism II: Pathophysiology

Hyperthyroidism is a hypermetabolic state caused by elevated levels of thyroid hormones, triiodothyronine (T3) and thyroxine (T4). It results from dysregulation at the thyroid, pituitary, or immune system level and affects multiple organ systems.PathophysiologyThe most common cause of hyperthyroidism is Graves’ disease, an autoimmune disorder in which antibodies, specifically thyroid-stimulating antibodies (TSAb), a subtype of TSH receptor antibodies (TRAb), bind to and activate TSH receptors...
Hyperthyroidism I: Introduction01:25

Hyperthyroidism I: Introduction

Hyperthyroidism is a type of thyrotoxicosis characterized by the thyroid gland's overproduction of the thyroid hormones triiodothyronine (T3) and thyroxine (T4). This hormone excess increases the basal metabolic rate and enhances sensitivity to catecholamines.DiagnosisDiagnosis is based on clinical features and biochemical testing. It typically shows suppressed thyroid-stimulating hormone (TSH) levels below 0.4 mIU/L, with elevated free T3 and/or T4. Additional tests, including thyroid...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...